1248 related articles for article (PubMed ID: 28231836)
1. Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
de Vega WC; Herrera S; Vernon SD; McGowan PO
BMC Med Genomics; 2017 Feb; 10(1):11. PubMed ID: 28231836
[TBL] [Abstract][Full Text] [Related]
2. Changes in DNA methylation profiles of myalgic encephalomyelitis/chronic fatigue syndrome patients reflect systemic dysfunctions.
Helliwell AM; Sweetman EC; Stockwell PA; Edgar CD; Chatterjee A; Tate WP
Clin Epigenetics; 2020 Nov; 12(1):167. PubMed ID: 33148325
[TBL] [Abstract][Full Text] [Related]
3. Identification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-associated DNA methylation patterns.
Trivedi MS; Oltra E; Sarria L; Rose N; Beljanski V; Fletcher MA; Klimas NG; Nathanson L
PLoS One; 2018; 13(7):e0201066. PubMed ID: 30036399
[TBL] [Abstract][Full Text] [Related]
4. Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Herrera S; de Vega WC; Ashbrook D; Vernon SD; McGowan PO
Epigenetics; 2018; 13(12):1174-1190. PubMed ID: 30516085
[TBL] [Abstract][Full Text] [Related]
5. Integration of DNA methylation & health scores identifies subtypes in myalgic encephalomyelitis/chronic fatigue syndrome.
de Vega WC; Erdman L; Vernon SD; Goldenberg A; McGowan PO
Epigenomics; 2018 May; 10(5):539-557. PubMed ID: 29692205
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid receptor DNA methylation and childhood trauma in chronic fatigue syndrome patients.
Vangeel EB; Kempke S; Bakusic J; Godderis L; Luyten P; Van Heddegem L; Compernolle V; Persoons P; Lambrechts D; Izzi B; Freson K; Claes S
J Psychosom Res; 2018 Jan; 104():55-60. PubMed ID: 29275786
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation modifications associated with chronic fatigue syndrome.
de Vega WC; Vernon SD; McGowan PO
PLoS One; 2014; 9(8):e104757. PubMed ID: 25111603
[TBL] [Abstract][Full Text] [Related]
8. A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction.
Sweetman E; Kleffmann T; Edgar C; de Lange M; Vallings R; Tate W
J Transl Med; 2020 Sep; 18(1):365. PubMed ID: 32972442
[TBL] [Abstract][Full Text] [Related]
9. Hypothalamic-Pituitary-Adrenal Hypofunction in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) as a Consequence of Activated Immune-Inflammatory and Oxidative and Nitrosative Pathways.
Morris G; Anderson G; Maes M
Mol Neurobiol; 2017 Nov; 54(9):6806-6819. PubMed ID: 27766535
[TBL] [Abstract][Full Text] [Related]
10. A targeted genome association study examining transient receptor potential ion channels, acetylcholine receptors, and adrenergic receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
Johnston S; Staines D; Klein A; Marshall-Gradisnik S
BMC Med Genet; 2016 Nov; 17(1):79. PubMed ID: 27835969
[TBL] [Abstract][Full Text] [Related]
11. Chronic Fatigue Syndrome and DNA Hypomethylation of the Glucocorticoid Receptor Gene Promoter 1F Region: Associations With HPA Axis Hypofunction and Childhood Trauma.
Vangeel E; Van Den Eede F; Hompes T; Izzi B; Del Favero J; Moorkens G; Lambrechts D; Freson K; Claes S
Psychosom Med; 2015 Oct; 77(8):853-62. PubMed ID: 26230484
[TBL] [Abstract][Full Text] [Related]
12. Bioenergetic and Proteomic Profiling of Immune Cells in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients: An Exploratory Study.
Fernandez-Guerra P; Gonzalez-Ebsen AC; Boonen SE; Courraud J; Gregersen N; Mehlsen J; Palmfeldt J; Olsen RKJ; Brinth LS
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209852
[TBL] [Abstract][Full Text] [Related]
13. Combined dexamethasone/corticotropin-releasing factor test in chronic fatigue syndrome.
Van Den Eede F; Moorkens G; Hulstijn W; Van Houdenhove B; Cosyns P; Sabbe BG; Claes SJ
Psychol Med; 2008 Jul; 38(7):963-73. PubMed ID: 17803834
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic Components of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Uncover Potential Transposable Element Activation.
Almenar-Pérez E; Ovejero T; Sánchez-Fito T; Espejo JA; Nathanson L; Oltra E
Clin Ther; 2019 Apr; 41(4):675-698. PubMed ID: 30910331
[TBL] [Abstract][Full Text] [Related]
15. Altered endothelial dysfunction-related miRs in plasma from ME/CFS patients.
Blauensteiner J; Bertinat R; León LE; Riederer M; Sepúlveda N; Westermeier F
Sci Rep; 2021 May; 11(1):10604. PubMed ID: 34011981
[TBL] [Abstract][Full Text] [Related]
16. Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study.
Lidbury BA; Kita B; Lewis DP; Hayward S; Ludlow H; Hedger MP; de Kretser DM
J Transl Med; 2017 Mar; 15(1):60. PubMed ID: 28302133
[TBL] [Abstract][Full Text] [Related]
17. Dynamic Epigenetic Changes during a Relapse and Recovery Cycle in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Helliwell AM; Stockwell PA; Edgar CD; Chatterjee A; Tate WP
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233152
[TBL] [Abstract][Full Text] [Related]
18. Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients.
Nguyen T; Johnston S; Chacko A; Gibson D; Cepon J; Smith P; Staines D; Marshall-Gradisnik S
Asian Pac J Allergy Immunol; 2017 Jun; 35(2):75-81. PubMed ID: 27362406
[TBL] [Abstract][Full Text] [Related]
19. Association of biomarkers with health-related quality of life and history of stressors in myalgic encephalomyelitis/chronic fatigue syndrome patients.
Fenouillet E; Vigouroux A; Steinberg JG; Chagvardieff A; Retornaz F; Guieu R; Jammes Y
J Transl Med; 2016 Aug; 14(1):251. PubMed ID: 27580693
[TBL] [Abstract][Full Text] [Related]
20. The expression signature of very long non-coding RNA in myalgic encephalomyelitis/chronic fatigue syndrome.
Yang CA; Bauer S; Ho YC; Sotzny F; Chang JG; Scheibenbogen C
J Transl Med; 2018 Aug; 16(1):231. PubMed ID: 30119681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
